Standout Papers

Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non–Small Cell Lung Cancer in t... 2021 2026 2022 2024350
  1. Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non–Small Cell Lung Cancer in the US (2021)
    Apar Kishor Ganti, Alyssa Klein et al. JAMA Oncology

Immediate Impact

77 standout
Sub-graph 1 of 24

Citing Papers

Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis
2024 Standout
Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents
2024 Standout
1 intermediate paper

Works of Engels Chou being referenced

Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non–Small Cell Lung Cancer in the US
2021 Standout
Safety and efficacy of insulin glargine 300 u/mL compared with other basal insulin therapies in patients with type 2 diabetes mellitus: a network meta-analysis
2016

Author Peers

Author Last Decade Papers Cites
Engels Chou 80 114 48 246 180 9 527
Dante diTommaso 32 110 19 324 149 6 521
P Zambon 87 91 14 162 265 15 563
Karen Cheng 86 47 20 244 257 11 605
Nancy Zuech 67 37 25 334 202 8 630
Timothy Judge 25 34 35 338 172 8 496
Myla Lai-Goldman 84 29 21 93 253 14 467
John R. Feagler 66 20 49 150 117 12 601
Yueping Jin 40 36 66 137 282 12 515
Claude Darte 19 77 7 216 107 15 511
Atte P. Kyllönen 25 75 83 159 139 14 576

All Works

Loading papers...

Rankless by CCL
2026